Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification.
Cortese M, Torchiaro E, D'Andrea A, Petti C, Invrea F, Franco L, Donini C, Leuci V, Leto SM, Vurchio V, Cottino F, Isella C, Arena S, Vigna E, Bertotti A, Trusolino L, Sangiolo D, Medico E.
Cortese M, et al. Among authors: torchiaro e.
Mol Ther. 2024 Aug 7;32(8):2741-2761. doi: 10.1016/j.ymthe.2024.06.023. Epub 2024 Jun 17.
Mol Ther. 2024.
PMID: 38894542
Free PMC article.